Skip to content

Commonsense health check decision a win for patients and GPs

By API User

The Royal Australian College of General Practitioners (RACGP) has welcomed a Medical Board of Australia (MBA) decision to not introduce mandatory health checks for GPs aged 70 and over. Rather than adding to the already burdensome regulatory environment for GPs, the RACGP has consistently argued that the focus should instead be on supporting doctors’ wellbeing. … Continued

Live on hair: Leukaemia Foundation dares Aussie radio hosts to ‘go bare’ for World’s Greatest Shave

By API User

  Australia’s leading blood cancer charity, the Leukaemia Foundation, is calling on radio hosts around the country to go bare for its iconic World’s Greatest Shave campaign in 2026.  For over 25 years, the flagship fundraiser has brought people together in solidarity to shave, cut or colour their hair, to raise vital funds for the 170,000 Australians living … Continued

Avance Clinical Launches Diversity in STEM Scholarships Across Australia and North America

By API User

ADELAIDE, Australia, Dec. 10, 2025 (GLOBE NEWSWIRE) — Avance Clinical, the award-winning global CRO for biotechs, has announced the launch of its new Diversity in STEM Scholarships, a global initiative designed to support women and minority-group students pursuing careers in science, technology, engineering, and mathematics (STEM). The program includes dedicated intakes in Australia and the broader … Continued

Biocytogen Completes STAR Market IPO, Becoming the First “H+A” Global Drug Innovator

By API User

BEIJING & SHANGHAI & HONG KONG–BUSINESS WIRE– Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen,” SSE: 688796; HKEX: 02315), a global biotechnology company advancing innovative drug discovery, today announced its successful listing on the Shanghai Stock Exchange STAR Market. This follows the Company’s listing on the Hong Kong Stock Exchange in September 2022 and marks a significant … Continued

Polpharma Biologics and Libbs Farmacêutica Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases

By API User

ZUG, Switzerland–BUSINESS WIRE– Polpharma Biologics, a leading biopharmaceutical company specializing in the development and manufacturing of biosimilars, is thrilled to announce the signing of a landmark licensing agreement with the Brazilian company Libbs Farmacêutica! Through this strategic partnership, Libbs Farmacêutica will gain exclusive rights to commercialize a cutting-edge biosimilar for autoimmune diseases in the rapidly … Continued

Ramsay Health Care makes landmark Australian investment in robotic surgical technology

By API User

Ramsay Health Care has made one of Australia’s largest single purchases of robotic surgical systems, with 12 new Stryker Mako robots set to be delivered to hospitals across the country over the next three months. The investment strengthens Ramsay’s commitment to modern, innovative health care options that support excellent patient outcomes. Ramsay Health Care’s Chief … Continued

First OncoSil treatment in United Kingdom

By API User

Sydney, Australia – 10 December 2025: OncoSil Medical Limited (ASX: OSL) (“OncoSil Medical” or “the Company”), a medical device company focused on localised treatments for patients with unresectable locally advanced pancreatic cancer (LAPC), is pleased to announce the first commercial patient treatment in the UK using the OncoSil™ device. The successful treatment was performed on … Continued